The 6th Glioblastoma Drug Development Summit explores approaches in glioblastoma drug development, focusing on innovative treatments, diagnostics, and clinical trial strategies.
Topics
- Overcoming the blood-brain barrier in glioblastoma treatments
- Advancing imaging techniques and biomarkers for glioblastoma diagnosis
- Optimizing immunotherapy and addressing the tumor microenvironment
- Unlocking the potential of combination therapies for glioblastoma
- Transforming glioblastoma clinical trial frameworks for future success
- Exploring new technologies and upcoming therapies disrupting current paradigms
- Insights into funding and partnerships for glioblastoma research
Who should Attend
- Oncologists and clinical researchers specializing in glioblastoma
- Biotech and pharmaceutical professionals focusing on brain cancer treatments
- Medical imaging and biomarker development experts
- Regulatory professionals and clinical trial coordinators
- Investors and funding organizations supporting glioblastoma research
- Neuroscientists and immunotherapy researchers
